Article
Myelodysplastic Syndromes
1 Jan 2002
Abstract excerpt
The myelodysplastic syndromes (MDS) are characterized by hemopoietic insufficiency associated with cytopenias leading to serious morbidity plus the additional risk of leukemic transformation. Therapeutic dilemmas exist in MDS because of the disease's multifactorial pathogenetic features, heterogeneous stages, and the patients' generally elderly ages. Underlying the cytopenias and evolutionary potential in MDS are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
